The Human Embryonic Stem Cell Debate

CHOICE Outstanding Academic Book for 2002

Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy.

This book offers a foundation for thinking about the many issues involved in human embryonic stem cell research. It considers questions about the nature of human life, the limits of intervention into human cells and tissues, and the meaning of our corporeal existence. The fact that stem cells may be derived from living embryos that are destroyed in the process or from aborted fetuses ties the discussion of stem cell research to the ongoing debates on abortion. In addition to these issues, the essays in the book touch on broader questions such as who should approve controversial research and what constitutes human dignity, respect, and justice. The book contains contributions from the Ethics Advisory Board of the Geron Coroporation; excerpts from expert testimony given before the National Bioethics Advisory Commission, which helped shape recent National Institutes of Health policy; and original analytical essays on the implications of this research.

As President Bush tries to make up his mind over the stem cell controversy, the issue remains headline news. The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy, edited by social ethics academics Suzanne Holland, Karen Lebacqz and Laurie Zoloth and third in MIT's Basic Bioethics series edited by Glenn McGee and Arthur Caplan, gathers 20 essays by scholars (including the editors) of theology, biology, medicine, medical and bioethics, philosophy and other disciplines. Fran‡oise Baylis discusses the National Bioethics Advisory Commission's recommendation that stem cell research be federally funded. Rabbi Elliott N. Dorff analyzes the debate through a Jewish theological lens. Thomas B. Okarma, president and CEO of Geron Corporation, a biotechnology corporation that initiated stem cell research in 1996, offers "A Primer on the Technology and Its Medical Applications." Others weigh in with Christian, Roman Catholic, historical, feminist, social justice and public policy perspectives. Three illus. Sept.)

Copyright 2001 Cahners Business Information, Inc.